Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema

British Journal of Dermatology

Volumn 141, Issue 6, 1999, Pages 1067-1075

  Lundberg, Lena ^a   Johannesson, M ^b   Silverdahl, M ^b   Hermansson, C ^b   Lindberg, M ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

Atopic eczema; Dermatology Life Quality Index; Health state utilities; Psoriasis; Quality of life; Rating scale; SF 36; Standard gamble; Time trade off; Willingness to pay

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; DISABILITY; DISEASE ACTIVITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SWEDEN;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; DERMATITIS, ATOPIC; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; SWEDEN;

EID: 0033388055     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03207.x     Document Type: Article

References (41)

1. 1 Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-96.
2. 2 Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
3. 3 Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-44.
4. 4 O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. Br Med J 1996; 313: 919-21.
5. 5 Katsambas A. Quality of life in dermatology and the EADV. J Eur Acad Dermatol Venereol 1994; 3: 211-14.
6. 6 Finlay AY, Ryan TJ. Disability and handicap in dermatology, Int J Dermatol 1996; 35: 305-11.
7. 7 Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
8. 8 Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Valuation of Health Care Programmes, 2nd edn. Oxford: Oxford Medical Publications, 1997.
9. 9 Torrance GW. Measurements of health status utilities for economic appraisal: a review, J Health Econ 1986; 5: 1-30.
10. 10 Mitchell RC, Carson RT. Using Surveys to Value Public Goods: The Contingent Valuation Method. Washington DC: Resources for the Future, 1989.
11. 11 Johannesson M, Jönsson B. Willingness to pay for antihypertensive therapy - results of a Swedish pilot study. J Health Econ 1991; 10: 461-74.
12. 12 Johannesson M, Johansson P-O, Kriström B, Gerdtham U. Willingness to pay for antihypertensive therapy - further results. J Health Econ 1993; 12: 95-108.
13. 13 Diener A, O'Brien B, Gafni A. Contingent valuation studies in the health care literature: a review and classification. Health Econ 1998; 7: 313-26.
14. 14 Zug KA, Littenberg B, Baughman RD et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 1995; 131: 561-8.
15. 15 Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14: 194-8.
16. 16 Finlay AY. Measures of the effect of adults severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol 1996; 7: 149-54.
17. 17 Ware JE, Sherbourne D. The MOS 36-item short form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
18. 18 Sullivan M, Karlsson J, Ware JE. Hälsoenkät SF-36. Svensk Manual och Tolkningsguide (SF-36 Health Survey. Swedish Manual and Interpretation Guide). Göteborg: Sahlgrenska University Hospital (English abstract), 1994.
19. 19 Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972; 7: 118-33.
20. 20 Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Ass Health Care 1989; 5: 559-75.
21. 21 Lundberg L, Johannesson M, Isacson D, Borgquist L. Health-state utilities in a general population in relation to age, gender, and socio-economic factors. Eur J Public Health 1999; 9: 211-17.
22. 22 Bishop RC, Heberlein TA. Measuring values of extramarket goods: are indirect measures biased? Am J Agr Econ 1979; 61: 926-30.
23. 23 Randall A, Ives B, Eastman C. Bidding games for valuation of aesthetic environmental improvements. J Environ Econ Manage 1974; 1: 132-49.
24. 24 Haneman WM. Welfare evaluations in contingent valuation experiments with discrete responses. Am J Agr Econ 1984: August: 332-41.
25. 25 Johansson P-O. Evaluating Health Risks: An Economic Approach. Cambridge: Cambridge University Press, 1985.
26. 26 Newbold P. Statistics for Business and Economics. 3rd edn. Englewood Cliffs, NJ: Prentice Hall, 1993.
27. 27 Greene WH. Econometric Analysis, 2nd edn. New York: Macmillan, 1993.
28. 28 Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality, Br J Dermatol 1995; 133: 575-8.
29. 29 Read JL, Quinn RJ, Berwick DM et al. Preference for health outcomes: comparison of assessment methods. Med Decision Making 1984; 4: 315-29.
30. 30 Hornberger JC, Redelmeier DA, Peterson J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45: 505-12.
31. 31 Bosch JL, Hunink MGM. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decision Making 1996; 16: 217-25.
32. 32 Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998; 80: 189-94.
33. 33 Kartman B, Andersson F, Johannesson M. Willingness to pay for reductions in angina pectoris attacks. Med Decision Making 1996; 16: 248-53.
34. 34 Holmes TP, Kramer RA. An independent sample test of yea-saying and starting point bias in dichotomous-choice contingent valuation. J Environ Econ Manage 1995; 29: 121-32.
35. 35 Green D, Jacowitz KE, Kahneman D, McFadden D. Referendum contingent valuation, anchoring, and willingness to pay for public goods. Resource Energy Econ 1998; 20: 85-116.
36. 36 Froberg DG, Kane RL. Methodology for measuring health-slate preferences II: scaling methods. J Clin Epidemiol 1989; 42: 459-71.
37. 37 Revicki DA. Relationship between health utility and psychometric health status measures. Med Care 1992; 30 (Suppl. 5): 274-82.
38. 38 O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preferences. Med Decision Making 1994; 14: 289-97.
39. 39 Johannesson M. Theory and Methods of Economic Evaluation of Health Care. Dordrecht: Kluwer, 1996.
40. 40 Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol 1998; 51: 1115-28.
41. 41 Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108.